Mashoko anoreva zvakafanana:

Panaxoside Rc;[20-[(6-O-α-L-Arabinofuranosyl-β-D-glucopyranosyl)oxy]-12β-hydroxydammar-24-en-3β-yl]2-O-β-D-glucopyranosyl-β -D-glucopyranoside;3β-[2-O-(β-D-Glucopyranosyl)-β-D-glucopyranosyloxy] -20-[6-O-(α-L-arabinofuranosyl)-β-D-glucopyranosyloxy]dammara- 24-ene-12β-ol;20-[(6-O-alpha-L-Arabinofuranosyl-beta-D-glucopyranosyl) oxy] -12b-hydroxydammar-24-en-3b-yl 2-O-β-D- glucopyranosyl-β-D-glucopyranoside;2- [(3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl) oxymethyl]-6- [1- [3-4,5-dihydroxy-6-methylol-] 3-(3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl)oxy-tetrahydropyran-2-yl]oxy-12-hydroxy-4,4,8,10,14-pentamethyl-2,3 ,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1,5-dimethyl-hex-4-enoxy]tetrahydropyran- 3,4,5-triol;2--[[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6--[2--[3-4,5-dihydroxy-6-() hydroxymethyl) -3- [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-oxan-2-yl]oxy-12-hydroxy-4,4,8,10,14-pentamethyl -2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-hept-5-en-2-yl]oxy-oxane-3,4,5-triol;2-[[3,4-dihydroxy-5-(hydroxymethyl)oxolan -2-yl]oxymethyl] -6- [2- [3-4,5-dihydroxy-6-(hydroxymethyl)-3--3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl ]oxyoxan-2-yl]oxy-12-hydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro -1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2-yl]oxyoxane-3,4,5-triol;Ginsenoside Rc ,98%

Canonical SMILES:CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)) CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(O8)CO)O)O)O)O)O)C

HS Kodhi:29389090

Density:1.42±0.1g/cm3(Zvakafanotaurwa)

Boiling Point:1128.3±65.0°C(Zvakafanotaurwa)

Melting Point:199～201℃

Kuchengeta:2-8°C

PKA:12.85±0.70(Zvakafanotaurwa)

Hazard Codes:Xn

Risk Statements:20/21/22

Safety Statements:26-36

WGK Germany:3